Description: An examination of LTCI rate increases from three different perspectives: the insurance company, the policyholder, and the insurance department.

Description: Summary of the National Conference on Group Practice of Medicine, held in Chicago from October 19-21, 1967 to explore means for stimulating the group practice of medicine.

Description: This presentation from Session 61PD of the SOA 1996 Orlando Annual Meeting provides an update on changes to the Medicare health program over the last couple years. In addition, the panelists discuss the merits of additional proposed changes from the White House and both sides of the aisle in Congress. From the Record of the Society of Actuaries, Vol. 22, No. 3.

Description: Presented at October 2000 Annual Meeting. Discusses demographic and economic change, changes in the market, and the direction of the legislative and legal environment for medical and long term care insurance.

Description: Panelists discuss the future of prospective payment in Medicare, sequels to the Omnibus Budget Reconciliation Act, the Deficit Reduction Act, COBRA, fallout from the administration's Catastrophic Illness Study, and the evolution of the voucher proposal. From the 1987 Record of Society of Actuaries, Vol. 13, No. 1.

Description: This actuarial memorandum represents the first, formal actuarial opinion regarding the reasonableness of the premium estimates the Clinton Administration presented with its proposed Health Security Act. The memorandum presents the assumptions and methods used to develop an average 1994 premium estimate for the standard benefit package.

Description: Overview of research project to investigate the extent of funding of public government retiree health programs.

Description: A summary of pathology, risk factors, treatments, public health issues, and economic costs of Alzheimer's Disease.

Description: Panel discussion of prospects for cost containment of, and alternatives to, fee-for-service health care, and management of health care under national health insurance. Discussion points include cost containment devices, HMOs, economic impact, cost escalation, self-insurance, stop-loss, claims administration, loss of state premium taxes, and Phase 3 tax problems under NH1.

Description: Prescribers, payers, and patients must put a higher priority on the comparative cost-effectiveness of competing pharmaceutical products if society is ever going to achieve rational and affordable drug use for all. From Prescription Drugs Monograph, M-HB04-1.